ACADIA Pharmaceuticals Inc (ACAD)

Inventory turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	81,841	45,731	10,166	19,141	20,550
Inventory	US$ in thousands	21,949	35,819	6,636	7,881	9,682
Inventory turnover		3.73	1.28	1.53	2.43	2.12

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $81,841K ÷ $21,949K
= 3.73

ACADIA Pharmaceuticals Inc's inventory turnover has displayed some fluctuations over the past five years. The inventory turnover ratio, which measures the company's efficiency in managing its inventory, increased from 2.12 in December 2020 to 2.43 in December 2021. However, there was a notable decline in inventory turnover to 1.53 in December 2022, indicating that the company took longer to turn over its inventory that year. This trend continued with a further decrease to 1.28 in December 2023, suggesting potential inventory management challenges.

Nevertheless, ACADIA Pharmaceuticals Inc saw a significant improvement in its inventory turnover in December 2024, with the ratio surging to 3.73. This sharp increase may indicate enhanced inventory management practices or a reduction in excess inventory levels during that period. Overall, the company's inventory turnover performance has been varied, with the most recent data point showing a marked improvement in inventory efficiency.